Clinical Efficacy of Crizotinib in Treatment of Patients with Advanced NSCLC
Background and objective Crizotinib was developed in recent years based on targets of anaplastic lymphoma kinase (ALK) fusion genes. The aim of this study is to explore the efficacy of crizotinib in treatment of non-small cell lung cancer (NSCLC) with ALK/ROS1 rearrangement. Methods Retrospective an...
Na minha lista:
| Principais autores: | , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Chinês |
| Publicado em: |
Chinese Anti-Cancer Association; Chinese Antituberculosis Association
2016-03-01
|
| coleção: | Chinese Journal of Lung Cancer |
| Assuntos: | |
| Acesso em linha: | http://dx.doi.org/10.3779/j.issn.1009-3419.2016.03.07 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|